Stroke:肥厚型心肌病患者根据房颤有无患缺血性卒中的情况

2021-10-06 MedSci原创 MedSci原创

HCM患者AF患病率高,IS风险明显,HCM患者伴有AF与较差的结局独立相关。一个简单的法国HCM评分显示了HCM患者中IS的良好预测和临床有用性,具有良好的校准。

肥厚型心肌病(HCM)患者发生缺血性卒中(IS)的风险很高,尤其是存在心房颤动(AF)的情况下。无论是否存在AF,都需要改进风险分层,以帮助识别卒中风险较高的HCM患者。

近日,血管疾病领域权威杂志Stroke上发表了一篇研究文章,这项来自涵盖2010年至2019年医院护理数据库的法国纵向队列研究分析了因孤立性HCM住院的成年人。研究人员使用Logistic回归模型构建法国HCM评分,并使用c指数和校准分析将其与HCM风险-CVA和CHA2DS2-VASc评分进行了比较。

在32206名孤立性HCM患者中,12498名(38.8%)患有AF,2489名(7.7%)患者在随访期间为持续IS。HCM患者的AF与更高的死亡风险(风险比为1.129[95%CI为1.088-1.172])、心血管死亡(风险比为1.254[95%CI为1.177-1.337])、IS(风险比为1.210[95%CI为1.111–1.317])和其他主要心血管事件相关。HCM患者中IS的独立预测因素包括年龄较大、心力衰竭、房颤、既往IS、吸烟和营养不良(所有P<0.05)。

对于HCM风险-CVA评分、CHA2DS2-VASc评分和法国HCM评分,所有c指数均为0.65至0.70,校准良好。在AF患者中,CHA2DS2-VASc评分比HCM风险-CVA评分略有改善,但与法国HCM评分相比预测性较差(P=0.001)。在没有AF的患者中,与CHA2DS2-VASc相比,HCM风险-CVA评分和法国HCM评分均具有显著更好的预测效能(均P<0.0001)。决策曲线分析表明,法国HCM评分在3个测试的风险评分中具有最佳的临床实用性。

由此可见,HCM患者AF患病率高,IS风险明显,HCM患者伴有AF与较差的结局独立相关。一个简单的法国HCM评分显示了HCM患者中IS的良好预测和临床有用性,具有良好的校准。

原始出处:

Laurent Fauchier.et al.Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy According to Presence or Absence of Atrial Fibrillation.stroke.2021.https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.034213

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1806460, encodeId=57aa1806460aa, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Mar 09 16:47:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893424, encodeId=d939189342451, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Jul 22 23:47:05 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622505, encodeId=6426162250595, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 07 23:47:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058344, encodeId=7b531058344b9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:28:27 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1806460, encodeId=57aa1806460aa, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Mar 09 16:47:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893424, encodeId=d939189342451, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Jul 22 23:47:05 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622505, encodeId=6426162250595, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 07 23:47:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058344, encodeId=7b531058344b9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:28:27 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1806460, encodeId=57aa1806460aa, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Mar 09 16:47:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893424, encodeId=d939189342451, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Jul 22 23:47:05 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622505, encodeId=6426162250595, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 07 23:47:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058344, encodeId=7b531058344b9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:28:27 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1806460, encodeId=57aa1806460aa, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Mar 09 16:47:05 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893424, encodeId=d939189342451, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Fri Jul 22 23:47:05 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622505, encodeId=6426162250595, content=<a href='/topic/show?id=b9578094833' target=_blank style='color:#2F92EE;'>#肌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80948, encryptionId=b9578094833, topicName=肌病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Thu Oct 07 23:47:05 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058344, encodeId=7b531058344b9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:28:27 CST 2021, time=2021-10-07, status=1, ipAttribution=)]
    2021-10-07 老龙一点

    学习

    0

相关资讯

Neurology:缺血性卒中后癫痫,有哪些预测因素?

卒中后癫痫发作与卒中的严重程度、病因和位置有关,而早期脑电图对癫痫没有预测作用。

Eur Heart J:首次检测到房颤的急性冠脉综合征患者缺血性卒中发生率和死亡率

在ACS患者中,与既往有AF病史的患者相比,首次检测到AF与1年缺血性卒中、死亡和出血发生率之间存在相关性。

Stroke:缺血性卒中患者亚急性期血压变异性与长期复发的关系

急性缺血性卒中亚急性期血压的日间变异性与卒中复发的长期风险增加相关。

Stroke:COVID-19感染对缺血性卒中患者结局的影响

与无COVID-19感染的缺血性卒中患者相比,COVID-19感染的缺血性卒中患者病情更严重,死亡率更高。然而,两组的功能结局相当。

FDA 批准卒中康复器械---迷走神经刺激Vivistim

卒中在中国每时每分都在发生,一旦发生如果 不及时治疗,患者轻则致残,重者死亡。无论卒中引发致残 和死亡都将给患者家庭和社会带来沉重负担 。

Ann Neurol:缺血性卒中后癫痫发作

卒中后癫痫发作与卒中严重程度、病因和位置有关,而早期脑电图不能预测癫痫。研究人员没有发现再灌注治疗与急性症状性癫痫发作或卒中后癫痫风险之间存在关联。